Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Medicine

Vol 9 No 2 (2024): December

S. aureus Colonization in Atopic Dermatitis Raises Global Concern
Kolonisasi S. aureus pada Dermatitis Atopik Menimbulkan Kekhawatiran Global



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.9150
Published
June 20, 2024

Abstract

Atopic Dermatitis (AD) is often worsened by Staphylococcus aureus colonization, which compromises the skin barrier and increases inflammation. This study aimed to identify risk factors for S. aureus infection in AD patients. Swabs from 100 AD patients at Baqubah Teaching Hospital, Iraq, were analyzed from October to February 2023. S. aureus was identified in 40% of patients using the Vitek 2 device. Results showed a significant correlation between S. aureus colonization and AD, particularly in younger patients, with the highest infection rates in males over 40. These findings highlight the need for targeted treatments to manage S. aureus in AD, potentially improving patient outcomes.

Highlights:

  1. High Infection Rates: S. aureus found in 40% of AD patients.
  2. Age Correlation: Higher colonization in younger AD patients.
  3. Targeted Treatment: Emphasize targeted therapies for managing S. aureus in AD.

Keywords: Atopic Dermatitis, Staphylococcus aureus, skin barrier, microbial dysbiosis, infection risk

References

  1. A. El-Ashry, R. H. El-Mahdy, M. A. Gaballah, and R. Talaat, "Staphylococcal cassette chromosome mec (SCCmec) typing and Gentamicin resistance in methicillin-resistant Staphylococcus aureus among children with atopic dermatitis in Egypt," Novel Research in Microbiology Journal, vol. 6, no. 6, pp. 1768-1782, 2022.
  2. T. Agner and K. A., "Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations," British Journal of Dermatology, vol. 177, no. 5, pp. 1394-1400, 2017.
  3. F. S. Cavalcante, C. V. D. C. G. Alvarenga, S. Saintive, E. D. Dios Abad, D. D. Carvalho Ferreira, and K. R. Netto dos Santos, "Staphylococcus aureus nasal isolates may have the same genetic profile in atopic dermatitis pediatric patients and their close contacts," Journal of Medical Microbiology, vol. 69, no. 6, pp. 850-853, 2020.
  4. A. El-Tawab, F. El Hofy, H. Sorour, M. Abd Ali, and R. H. Hamouda, "Molecular characterization of some antibiotic resistant genes of Staphylococcus aureus isolated from different sources and human," Benha Veterinary Medical Journal, vol. 41, no. 2, pp. 6-10, 2022.
  5. A. Damour, M. Garcia, J. Seneschal, N. Lévêque, and C. Bodet, "Eczema herpeticum: clinical and pathophysiological aspects," Clinical Reviews in Allergy and Immunology, vol. 59, pp. 1-18, 2020.
  6. G. Damiani, P. Calzavara‐Pinton, L. Stingeni, K. Hansel, F. Cusano et al., "Italian guidelines for therapy of atopic dermatitis—Adapted from consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis)," Dermatologic Therapy, vol. 32, no. 6, article e13121, 2019.
  7. A. Conwill, A. C. Kuan, R. Damerla, A. J. Poret, J. S. Baker et al., "Anatomy promotes neutral coexistence of strains in the human skin microbiome," Cell Host and Microbe, vol. 30, no. 2, pp. 171-182, 2022.
  8. R. Chopra, P. P. Vakharia, R. Sacotte, and J. I. Silverberg, "Efficacy of bleach baths in reducing severity of atopic dermatitis: a systematic review and meta-analysis," Annals of Allergy, Asthma and Immunology, vol. 119, no. 5, pp. 435-440, 2017.
  9. B. Cabanillas, "Dupilumab for Atopic Dermatitis—From Clinical Trials to Molecular and Cellular Mechanisms," Dermatitis, vol. 34, no. 1, pp. 21-28, 2023.
  10. H. Baurecht, M. C. Rühlemann, E. Rodríguez, F. Thielking, I. Harder et al., "Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration," Journal of Allergy and Clinical Immunology, vol. 141, no. 5, pp. 1668-1676, 2018.
  11. R. P. Adhikari, S. Shrestha, A. Barakoti, and R. Amatya, "Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal," BMC Infectious Diseases, vol. 17, no. 1, pp. 1-5, 2017.
  12. C. Altunbulakli, M. Reiger, A. U. Neumann, N. Garzorz-Stark, M. Fleming et al., "Relations between epidermal barrier dysregulation and Staphylococcus species–dominated microbiome dysbiosis in patients with atopic dermatitis," Journal of Allergy and Clinical Immunology, vol. 142, no. 5, pp. 1643-1647, 2018.
  13. M. H. Effendi, M. A. M. Hisyam, P. Hastutiek, and W. Tyasningsih, "Detection of coagulase gene in Staphylococcus aureus from several dairy farms in East Java, Indonesia, by polymerase chain reaction," Veterinary World, vol. 12, no. 1, 2019.
  14. N. Ahmad-Mansour, P. Loubet, C. Pouget, C. Dunyach-Remy, A. Sotto et al., "Staphylococcus aureus toxins: An update on their pathogenic properties and potential treatments," Toxins, vol. 13, no. 10, article 677, 2021.
  15. R. van R. S., M. van der Zwart, M. Schmelcher, "Linker-improved chimeric endolysin selectively kills Staphylococcus aureus in vitro, on reconstituted human epidermis, and in a murine model of skin infection," Antimicrobial Agents and Chemotherapy, vol. 66, no. 5, article e02273-21, 2022.
  16. L. Flowers and E. A. Grice, "The skin microbiota: balancing risk and reward," Cell Host and Microbe, vol. 28, no. 2, pp. 190-200, 2020.
  17. S. M. George, S. Karanovic, D. A. Harrison, A. Rani, A. J. Birnie et al., "Interventions to reduce Staphylococcus aureus in the management of eczema," Cochrane Database of Systematic Reviews, no. 10, 2019.
  18. M. Grazul, E. Balcerczak, and M. Sienkiewicz, "Analysis of the Presence of the Virulence and Regulation Genes from Staphylococcus aureus (S. aureus) in Coagulase Negative Staphylococci and the Influence of the Staphylococcal Cross-Talk on Their Functions," International

Downloads

Download data is not yet available.